Skip to Content

LTM Wins a USD 100 Million Deal with European MedTech

As part of this agreement, LTM will develop and support MedTech’s primary hearing instrument brands and its private labels.
February 23, 2026 by
LTM Wins a USD 100 Million Deal with European MedTech
DSIJ Intelligence
| No comments yet

LTIMindtree, the Business Creativity partner to the world’s largest enterprises, today announced a multi-year, USD 100 million strategic agreement with a MedTech company in Europe, a leading provider of innovative hearing solutions, to deliver Service development and support across its flagship products. This agreement will span over seven years. Towards this, LTM will leverage iNXT, its cross-industry digital transformation and innovation platform designed to help enterprises manage the convergence of the physical and digital worlds.

As part of this agreement, LTM will develop and support the MedTech’s primary hearing instrument brands and its private labels. This includes the MedTech’s core wearable devices, the fitting application used by hearing care professionals to configure hearing aids, and the mobile application for device control. Along with technological development and support, LTM will lead and navigate complex MedTech compliance & regulatory frameworks for the client.

About the Company

LTIMindtree is a global technology consulting and digital solutions company that partners with enterprises across industries to reimagine business models, accelerate innovation, and drive AI-centric growth. Trusted by more than 700 clients worldwide, we use advanced technologies to enable operational excellence, elevated customer experiences, and long-term value creation. With a workforce of more than 86,000 talented and entrepreneurial professionals across over 40 countries, LTIMindtree — a Larsen & Toubro Group company — is dedicated to solving complex business challenges and delivering transformation at scale.

LTIMindtree's market capitalisation is Rs 1.43 lakh crore. The stock is up by 27 per cent from its 52-week low of Rs 3,841.05 per share with a PE of 28x, an ROE of 22 per cent and an ROCE of 28 per cent.

Disclaimer: The article is for informational purposes only and not investment advice. 

Choose consistency over uncertainty. DSIJ’s Large Rhino identifies India’s strongest blue chips for reliable wealth building.

Download Brochure​​​​​​


LTM Wins a USD 100 Million Deal with European MedTech
DSIJ Intelligence February 23, 2026
Share this post
Archive
Sign in to leave a comment